THYROID STIMULATING HORMONE-EIA-XT— 510(k) K896867
Substantially EquivalentIn Vitro Diagnostics, Inc.
FDA 510(k) clearance K896867 for THYROID STIMULATING HORMONE-EIA-XT, Substantially Equivalent on 1990-02-23. Applicant: In Vitro Diagnostics, Inc.. Device class: 2.
Clearance details
- Applicant
- In Vitro Diagnostics, Inc.
- Product code
- Code JLW
- Device class
- Class 2
- Regulation
- 21 CFR 862.1690
- Advisory panel
- Clinical Chemistry
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Littleton, CO, US
Recent devices under product code JLW
view all- K251543 — Atellica® IM TSH3-Ultra II (TSH3ULII)
- K243570 — Dimension LOCI Thyroid Stimulating Hormone Flex reagent cartridge (TSHL) +1 more
- K234091 — Maverick Diagnostic System TC1000; Maverick Test Panel A0.B0
- K233050 — ADVIA Centaur® TSH3-Ultra II (TSH3ULII)
- K222116 — Atellica® CI Analyzer, Atellica® IMThyroid Stimulating Hormone 3-Ultra (TSH3-UL), Atellica® CH Albumin BCP (AlbP)
More clearances from In Vitro Diagnostics, Inc.
view allAdverse events under product code JLW
product code JLW- Malfunction
- 885
- Total
- 885
Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →
Data sourced from openFDA. This site is unofficial and independent of the FDA.